Therapy Access
Access Built Over Years. Delivered Day One.
The Challenge
Evolving payer requirements, limited distribution networks, and administrative complexity can delay therapy, fragment care, and make it harder for patients to stay connected to their health system.
Partner Health Systems
Why Health Systems Partner With Us
Dedicated payer and drug access teams help health systems gain, maintain, and expand access while reducing operational burden through unmatched industry relationships.
Dedicated Expertise
Proven Relationships
Network Scale
Ongoing Support
PATIENT ACCESS
Our Access Solutions
Every health system's path to access is different. That's why we offer a specialized and strategic approach that helps our partners navigate complexity, unlock new opportunities, and build a stronger foundation for long-term growth.
Our team of highly specialized payer access experts with experience across every aspect of health system and pharmacy contracting, from PBM pathways and managed care to direct network agreements.
As manufacturer requirements evolve, our drug access and trade relations teams help health systems navigate complexity and maintain access to specialty and limited distribution therapies.
Payer Access & Contracting Capabilities
We bring unmatched depth across the capabilities that drive payer access:
Customized strategic payer roadmap
Direct to employer contracting
Direct to employer contracting
Network-level contracting
Managed care contracting
PBM application support
Gap analysis and payer readiness support
Clinical outcomes and reporting
Payer Access & Contracting Results
$42B
Access Unlocked
90%+
Commercial Payer Access Acheived
1,000+
Contracts Secured
~500
Reports Produced Annually to Maintain Payer Access on Behalf of Our Partners
Drug Access & Trade Relations
We help our partners expand and maintain drug access through:
Manufacturer engagement and relationship management
Strategic drug-specific program and design
Limited distribution drug access strategies
Launch readiness planning
Drug pipeline monitoring
Access expansion initiatives
Enhanced data reporting and ETASU REMS programs
Ongoing trade relations support
The Results
90%+
Limited Distribution Drug Access
<2 Days
Days Average Time to Therapy (PA TAT)
93%
Proportion of Days Covered (PDC)/Adherence rate
Get the Access That Powers Connected Performance
Expand access. Strengthen performance. Keep specialty care where it belongs.